Dapagliflozin: A Sodium Glucose Cotransporter 2 Inhibitor for the Treatment of Diabetes Mellitus
Conclusion:
Dapagliflozin is effective for the treatment of type 2 diabetes.
Source: Journal of Pharmacy Practice - Category: Drugs & Pharmacology Authors: Davis, P. N., Ndefo, U. A., Oliver, A. Tags: Review Articles Source Type: research
More News: AstraZeneca | Clinical Trials | Dapagliflozin | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Forxiga | Insulin